A new screening test for cervical cancer being introduced in some countries and considered in many others may in fact be worse than the test it is replacing, suggests controversial new research. The ...

Truscreen Group Ltd. completed its largest clinical trial to date that showed its cervical cancer screening device surpassed liquid-based cytology (LBC) screening in 15,651 women across 64 hospitals ...

Liquid-based cytology (LBC) is widely used for the primary screening of cervical cancer, but its accuracy has not been tested in a large randomized trial. To address this situation, Ronco et al.

Cervical cancer remains a significant global health challenge, particularly affecting women in low-resource settings. Effective screening methods are essential for early detection and prevention. This ...

A new computerised screening test for cervical cancer detects more abnormalities than the traditional smear test, according to a study published on bmj.com today. It could also lead to fewer women ...

In addition to the information depicted in Table 1, primary-care clinicians need to be aware of the findings of research studies that surround the administration of the cervical cancer vaccines. This ...